Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

Clinical trial NCT04329065 · RECRUITING

Trial details

NCT number: NCT04329065
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Anatomic Stage I Breast Cancer AJCC v8 Anatomic Stage II Breast Cancer AJCC v8 Anatomic Stage III Breast Cancer AJCC v8

Start date: 2022-04-20
Primary completion: 2026-12-31
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.